Efren Delos Santos
Publications by Year
Research Areas
PI3K/AKT/mTOR signaling in cancer, Chronic Lymphocytic Leukemia Research, Quinazolinone synthesis and applications, HER2/EGFR in Cancer Research, Biochemical and Molecular Research
Most-Cited Works
- → Bis(morpholino-1,3,5-triazine) Derivatives: Potent Adenosine 5′-Triphosphate Competitive Phosphatidylinositol-3-kinase/Mammalian Target of Rapamycin Inhibitors: Discovery of Compound 26 (PKI-587), a Highly Efficacious Dual Inhibitor(2010)211 cited
- → Antitumor Efficacy of PKI-587, a Highly Potent Dual PI3K/mTOR Kinase Inhibitor(2011)169 cited
- → Lead Optimization of N-3-Substituted 7-Morpholinotriazolopyrimidines as Dual Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Inhibitors: Discovery of PKI-402(2009)78 cited
- → PKI-179: An orally efficacious dual phosphatidylinositol-3-kinase (PI3K)/mammalian target of rapamycin (mTOR) inhibitor(2010)71 cited
- → 2,4-Diamino-quinazolines as inhibitors of β-catenin/Tcf-4 pathway: Potential treatment for colorectal cancer(2009)69 cited
- → Antitumor Efficacy Profile of PKI-402, a Dual Phosphatidylinositol 3-Kinase/Mammalian Target of Rapamycin Inhibitor(2010)59 cited
- → Acetylenic TACE inhibitors. Part 1. SAR of the acyclic sulfonamide hydroxamates(2003)49 cited
- → Structure–activity study of novel tricyclic benzazepine arginine vasopressin antagonists(2003)41 cited
- → Novel purine and pyrazolo[3,4-d]pyrimidine inhibitors of PI3 kinase-α: Hit to lead studies(2009)38 cited
- → Benzodiazepine inhibitors of the MMPs and TACE(2002)32 cited